Organigram
Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a
leading licensed producer of cannabis, is advancing on its goal to increase its
licensed production capacity to 76,000 kilograms per year. An article
discussing the company reads, “Additional construction outlined in phase 4B of
the company’s expansion plans is on schedule to be completed later this month.
The company plans on submitting the licensing amendment for its remaining 16
phase 4B cultivation rooms this month as well. The perimeter of phase 5 of the
company’s expansion, which will include an edibles and derivative product
facility and more extraction capacity, is also planned for this Health Canada
licensing submission (http://ibn.fm/beQXS).”
To view the full article, visit http://ibn.fm/mTCak
About Organigram Holdings Inc.
Organigram Holdings is a Toronto Stock Exchange and NASDAQ
Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is
a licensed producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing the highest-quality, indoor-grown cannabis
for patients and adult-recreational consumers in Canada, as well as developing
international business partnerships to extend the company’s global footprint. Organigram
has also developed a portfolio of legal adult-use recreational cannabis brands
including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and
Trailblazer. Organigram’s primary facility is located in Moncton, New
Brunswick, and the company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada). For more information, visit the company’s website
at www.Investors.Organigram.ca.
NOTE TO INVESTORS: The latest news and updates
relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
